Article 1
1. The Community shall purchase as soon as possible the following strains of foot-and-mouth disease antigen:
- A Malaysia 97: 1500000 doses,
- SAT1: 1500000 doses,
- SAT2 (Southern Africa): 1500000 doses,
- SAT2 (East Africa): 1500000 doses,
- SAT3: 1500000 doses,
- ASIA1: 1500000 doses,
- O1 - Manisa: 1500000 doses,
- A22 - Iraq: 1500000 doses.
2. The Community shall make arrangements for the storage of antigen and the formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens referred to in paragraph 1.
3. The maximum cost of the measures referred to in paragraphs 1 and 2 shall be up to EUR 2650000.
4. The action referred to above shall be organised by the Commission before 31 December 2000.
